You are currently viewing a new version of our website. To view the old version click .

Advances and Challenges in Nasal Formulation Developments, 2nd Edition

This special issue belongs to the section “Pharmaceutical Technology, Manufacturing and Devices“.

Special Issue Information

Dear Colleagues,

Intranasal administration has the potential as a targeting system for various tissues (e.g., brain targeting, lymphatic delivery, mucosal vaccination and transmucosal absorption). The development of nasal formulations is difficult due to factors such as the retention time in the nasal cavity, dose restriction, animal species difference and individual variation in nasal drug absorption. This Special Issue will address the advances in various forms of nasal formulations, including in vivo and in vitro evaluations of drug permeation and disposition, drug dissolution from formulations, the development of novel dosage forms and excipients for nasal applications. Additionally, it will include studies on drug targeting from nose to brain/lymphatic tissue, nasal vaccination and mucosal absorption. Original research papers and review articles are welcomed.

Dr. Daisuke Inoue
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • nasal formulations
  • intranasal dissolution and permeation
  • mucosal absorption
  • excipients for nasal formulations
  • in vitro dissolution system
  • in vivo nasal dissolution and absorption

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmaceutics - ISSN 1999-4923